Sign in
4/A

Changes in Ownership

Processa Pharmaceuticals, Inc. Filed Acc 0000897069-26-000977

Chief Executive Officer bought 2,136 shares at $2.54 ($5,415)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ng George K Chief Executive Officer 2026-03-31 Purchase +2,136 $2.54 $5,415 2,136 D
Open-market purchases · 2,136 sh · avg $2.54 · $5,415
Loading xslF345X06/form4a.xml…